Brief: NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement With Investor David Lazar
19/08/2025 22:39
Aug 19 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A: NOVABAY PHARMACEUTICALS ENTERS INTO $6 MILLION SECURITIES PURCHASE AGREEMENT WITH INVESTOR DAVID E. LAZAR NOVABAY PHARMACEUTICALS INC - DAVID E. LAZAR APPOINTED AS NOVABAY'S CEO AND DIRECTOR NOVABAY PHARMACEUTICALS INC - EXPECTS TO DECLARE SPECIAL CASH DIVIDEND IN Q3 2025 Source text: ID:nGNX1QDjnM Further company coverage: NBY.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing